Patents by Inventor Ghislaine Gallez-Hawkins

Ghislaine Gallez-Hawkins has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cytomegalovirus vaccine
    Publication number: 20080138354
    Abstract: This specification discloses a Cytomegalovirus vaccine which employs nuclear localization signal knock-out to improve vaccine immunogenicity and antigen presentation in a combined DNA and recombinant adeno-associated viral vector vaccination (rAAV) system.
    Type: Application
    Filed: July 23, 2007
    Publication date: June 12, 2008
    Applicant: City of Hope
    Inventors: John A. Zaia, Ghislaine Gallez-Hawkins
  • CMV-IE1 peptides and method of use
    Publication number: 20050232933
    Abstract: IE1 peptide antigens that are recognized by and stimulate production of CMV-specific cytotoxic T lymphocytes are useful for vaccines, in the form of peptides, DNA vaccines or cellular vaccines, and also for diagnostic methods.
    Type: Application
    Filed: September 30, 2004
    Publication date: October 20, 2005
    Inventors: John Zaia, Ghislaine Gallez-Hawkins